Literature DB >> 19541532

Hidden killers: persistence of opportunistic fungal pathogens in the human host.

Christophe d'Enfert1.   

Abstract

Opportunistic fungal pathogens are responsible for life-threatening systemic infections in immunocompromized individuals. Yet, they are also able to persist in immunocompetent individuals through different strategies. This review explores recent advances in our understanding of several survival strategies: the establishment of a commensal relationship between yeast of the genus Candida and the host; the formation of biofilms that allow microbes in these communities to be protected from chemical and cellular attacks; and the persistence of airborne pathogens within macrophages following primary infection. While research has concentrated on deciphering virulence factors of pathogenic fungi, additional understanding of how fungal pathogens persist in healthy hosts might help us design new strategies to prevent the transition from harmless interactions to devastating infections.

Entities:  

Mesh:

Year:  2009        PMID: 19541532     DOI: 10.1016/j.mib.2009.05.008

Source DB:  PubMed          Journal:  Curr Opin Microbiol        ISSN: 1369-5274            Impact factor:   7.934


  32 in total

1.  Antimicrobial blue light inactivation of Candida albicans: In vitro and in vivo studies.

Authors:  Yunsong Zhang; Yingbo Zhu; Jia Chen; Yucheng Wang; Margaret E Sherwood; Clinton K Murray; Mark S Vrahas; David C Hooper; Michael R Hamblin; Tianhong Dai
Journal:  Virulence       Date:  2016-02-24       Impact factor: 5.882

Review 2.  The regulation of filamentous growth in yeast.

Authors:  Paul J Cullen; George F Sprague
Journal:  Genetics       Date:  2012-01       Impact factor: 4.562

3.  Unmasking fungal pathogens by studying MAPK-dependent cell wall regulation in Candida albicans.

Authors:  Paul J Cullen; Mira Edgerton
Journal:  Virulence       Date:  2016-04-18       Impact factor: 5.882

4.  Addition of DNase improves the in vitro activity of antifungal drugs against Candida albicans biofilms.

Authors:  Margarida Martins; Mariana Henriques; José L Lopez-Ribot; Rosário Oliveira
Journal:  Mycoses       Date:  2011-06-12       Impact factor: 4.377

5.  Penicillenols from a deep-sea fungus Aspergillus restrictus inhibit Candida albicans biofilm formation and hyphal growth.

Authors:  Jie Wang; Qi-Feng Yao; Muhammad Amin; Xu-Hua Nong; Xiao-Yong Zhang; Shu-Hua Qi
Journal:  J Antibiot (Tokyo)       Date:  2017-04-05       Impact factor: 2.649

Review 6.  Antibacterial and Antiviral Functional Materials: Chemistry and Biological Activity toward Tackling COVID-19-like Pandemics.

Authors:  Bhuvaneshwari Balasubramaniam; Sudhir Ranjan; Mohit Saraf; Prasenjit Kar; Surya Pratap Singh; Vijay Kumar Thakur; Anand Singh; Raju Kumar Gupta
Journal:  ACS Pharmacol Transl Sci       Date:  2020-12-29

7.  Reverse genetics in Candida albicans predicts ARF cycling is essential for drug resistance and virulence.

Authors:  Elias Epp; Ghyslaine Vanier; Doreen Harcus; Anna Y Lee; Gregor Jansen; Michael Hallett; Don C Sheppard; David Y Thomas; Carol A Munro; Alaka Mullick; Malcolm Whiteway
Journal:  PLoS Pathog       Date:  2010-02-05       Impact factor: 6.823

8.  Signalling mucin Msb2 Regulates adaptation to thermal stress in Candida albicans.

Authors:  Darpan Saraswat; Rohitashw Kumar; Tanaya Pande; Mira Edgerton; Paul J Cullen
Journal:  Mol Microbiol       Date:  2016-02-10       Impact factor: 3.501

Review 9.  The vaginal mycobiome: A contemporary perspective on fungi in women's health and diseases.

Authors:  L Latéy Bradford; Jacques Ravel
Journal:  Virulence       Date:  2016-09-22       Impact factor: 5.882

10.  Fungal echinocandin resistance.

Authors:  Louise A Walker; Neil A R Gow; Carol A Munro
Journal:  Fungal Genet Biol       Date:  2009-09-19       Impact factor: 3.495

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.